If you’re keeping an eye on the gh stock price today, you’ve come to the right spot. Guardant Health is a company that gets talked about a lot, especially with how its stock moves during the day. This article is here to break down the latest numbers, what they might mean, and a bit about the company itself. Whether you’re thinking about investing or just want to stay updated, we’ll keep things simple and easy to follow. Let’s get into the details and see what’s happening with Guardant Health right now.
Key Takeaways
- Guardant Health’s stock price today opened at $104.00 and is currently trading around $104.24.
- The 52-week price range for GH stock stretches from $34.88 to $120.74, showing a lot of movement over the past year.
- Trading volume today is around 38,000 shares, with an average daily volume of about 2.23 million shares.
- Guardant Health does not pay a dividend, and its P/E ratio is negative due to recent losses.
- The company is based in Palo Alto, California, and is led by Helmy Eltoukhy and a team focused on cancer diagnostics.
Guardant Health Stock Price Today: Live Market Data
Staying up to date on Guardant Health’s stock activity can feel like checking the weather before heading out. You just want the numbers, quick and easy. Here’s a breakdown of GH stock as of this morning.
Current GH Stock Price
As of 9:36 AM EST, Guardant Health (NASDAQ: GH) is trading at $104.24 per share. It’s down $0.61, or about 0.59% compared to the previous close. Prices can shift every second when markets are open. So, if you’re tracking the price, refresh often or set up alerts.
| Time | Price | Change | % Change |
|---|---|---|---|
| 9:36 AM EST | $104.24 | -$0.61 | -0.59% |
Real-Time Trading Volume
Trading volume tells you how many shares are changing hands. It can point to how much interest people have in the stock today. For Guardant Health:
- Shares traded so far: 38,011
- Average 10-Day Volume: 2.23 million
- Shares Outstanding: 128.84 million
Some days, trading volume spikes. That usually means news or rumors are making people want to buy or sell.
Today’s Opening and Closing Prices
Here’s the quick numbers for today:
- Opening Price: $104.00
- Previous Close (yesterday’s final price): $104.85
During the day, Guardant Health’s stock hit a high of $104.89 and dropped as low as $102.00 so far. If you want to see how things compare to other days, the closing price later today tells that story.
At a glance:
| Metric | Value |
|---|---|
| Open | $104.00 |
| Prev Close | $104.85 |
| Day’s High | $104.89 |
| Day’s Low | $102.00 |
If you’re watching GH, keep an eye on these stats throughout the day—they’ll show you if today’s a calm ride or a rollercoaster.
Guardant Health Stock Performance Analysis
Looking at how Guardant Health’s stock has been doing lately gives us a good idea of its current market standing. It’s not just about the price today, but also how it’s moved over different periods.
52-Week High and Low for GH Stock
The stock has seen a pretty wide range over the past year. The 52-week high hit $120.74 on January 22, 2026, showing a peak in investor confidence. On the flip side, the 52-week low was $34.88, recorded on March 10, 2025. This big difference between the high and low tells us there’s been a lot of movement and perhaps some significant shifts in how the market views the company.
Day’s Trading Range and Volatility
Today, the trading range has been between $102.00 and $104.89. This suggests a moderate level of activity for the day, not too wild but definitely some back-and-forth. Volatility is something to keep an eye on; a wider range usually means more price swings, which can be good for traders but maybe a bit nerve-wracking for long-term holders.
Comparison to Previous Close
As of the latest update, the stock is trading at $104.24, which is down $0.61 from its previous closing price of $104.85. This slight dip indicates a bit of selling pressure today, but it’s important to see if this trend continues or reverses as the trading day progresses.
Key Financial Metrics for Guardant Health
Market Capitalization of GH
Guardant Health’s market capitalization, which represents the total value of all its outstanding shares, currently stands at approximately $13.43 billion. This figure gives us a snapshot of how the market values the company as a whole. It’s a big number, sure, but what does it really mean in the grand scheme of things?
Outstanding Shares and Average Volume
When we talk about outstanding shares, we’re looking at the total number of shares that have been issued by the company and are held by investors. Guardant Health has about 128.84 million shares out there. Then there’s the average daily trading volume, which for Guardant Health is around 2.23 million shares over a 10-day period. This tells us how much the stock is typically bought and sold each day. A higher volume can sometimes mean more interest or liquidity in the stock.
Beta and Its Implications
Beta is a measure of a stock’s volatility in relation to the overall market. A beta of 1.66, like Guardant Health’s, suggests that the stock tends to be more volatile than the market. This means that if the market goes up by 10%, GH stock might move up by more than 16.6%, and if the market drops by 10%, GH stock could fall by more than 16.6%. Investors often consider beta when assessing risk. It’s important to remember that past performance, including beta, isn’t a crystal ball for future results. For a deeper look at the company’s valuation and recent activity, you might want to check out Guardant Health’s stock performance.
Here’s a quick look at these metrics:
| Metric | Value |
|---|---|
| Market Cap | $13.43 Billion |
| Outstanding Shares | 128.84 Million |
| 10-Day Avg Volume | 2.23 Million |
| Beta | 1.66 |
Guardant Health’s Profitability and Ratios
Let’s talk about how Guardant Health is doing financially, specifically looking at its profitability and some key ratios. It’s not always easy to make sense of these numbers, but they tell a story about the company’s health.
Earnings Per Share (EPS) Trends
Guardant Health’s Earnings Per Share, or EPS, has been a bit of a mixed bag. For the trailing twelve months (TTM), the EPS is reported at -3.21. This negative number means the company is currently losing money on a per-share basis. It’s important to keep an eye on this trend to see if it improves over time.
Price-to-Earnings (P/E) Ratio Analysis
When we look at the Price-to-Earnings (P/E) ratio, it’s also negative for the TTM at -32.44. A negative P/E usually happens when a company isn’t profitable. For future expectations, the Forward P/E (NTM) is around -40.88. While a high P/E can sometimes indicate growth expectations, a negative one points to current unprofitability. It’s worth noting that Guardant Health’s current price-to-sales ratio is quite a bit higher than the average for the US Healthcare sector, which is something to consider when looking at valuation metrics.
Revenue and Gross Margin Insights
On the revenue side, Guardant Health’s TTM revenue stands at $902.569 million. That’s a decent amount of money coming in. What’s also positive is the Gross Margin, which is 63.76% for the TTM. This means that after accounting for the direct costs of producing their tests and services, the company keeps a good chunk of its revenue. A strong gross margin is a good sign, even if the company isn’t profitable overall yet.
Here’s a quick look at some of these numbers:
| Metric | Value (TTM) |
|---|---|
| Revenue | $902.57M |
| Gross Margin | 63.76% |
| EPS | -$3.21 |
| P/E Ratio | -32.44 |
It’s a complex picture, with strong revenue and gross margins, but still showing losses on the bottom line. Investors will be watching closely to see how these profitability metrics evolve.
Understanding Guardant Health’s Debt and Equity
Debt-to-Equity Ratio Explained
When we look at a company’s financial health, how it manages its money is a big deal. One way to check this is by looking at its debt-to-equity ratio. Basically, this tells you how much debt a company is using to fund its operations compared to the value of its shareholders’ equity. For Guardant Health, the Debt-to-Equity ratio is currently around 0.11. This is a pretty low number, which generally means the company isn’t relying heavily on borrowed money. A lower ratio often suggests less financial risk for investors. It means that if things got tough, the company has more of its own money (equity) than borrowed money (debt) to fall back on. This can be a good sign, showing a stable financial structure.
Net Margin Performance
Net margin is another key figure that shows how much profit a company makes after all expenses are paid. For Guardant Health, the net margin has been negative, sitting at around -44.18% (TTM). This means that for every dollar of sales, the company is currently spending more than a dollar, resulting in a loss. It’s not uncommon for companies, especially those in growth phases like Guardant Health, to have negative net margins as they invest heavily in research, development, and expanding their market reach. However, it’s something investors watch closely. We’ll want to see this number improve over time as the company scales its operations and its revenue grows. Keeping an eye on this trend is important for understanding the company’s path toward profitability. The current Debt to Equity ratio is a positive indicator, but the net margin shows where the focus needs to be for future growth.
Upcoming Events for Guardant Health Investors
If you’re keeping tabs on Guardant Health, there are a couple of important dates and info points that shouldn’t slip by. Paying attention to their event calendar can really help you stay updated on price trends and company decisions that might influence your investment strategies.
Anticipated Earnings Dates
Guardant Health always shares their financial results every quarter. According to the current schedule, the next earnings announcement is planned for February 19, 2026. Here are some tips to get ready for that day:
- Mark your calendar for February 19, 2026 – that’s when the next earnings numbers come out.
- Check previous reports for revenue and EPS trends to see if the company usually meets or misses expectations.
- Watch for management’s comments in the earnings call, which often provide more insight than the numbers alone.
Dividend and Stock Split Information
As it stands today, Guardant Health does not pay a dividend and hasn’t announced an upcoming stock split. But it’s still smart to watch for changes, because these actions can shift a stock’s price and its appeal to investors.
| Date | Dividend Announced | Ex-Dividend Date | Stock Split Announced | Split Date |
|---|---|---|---|---|
| Feb 17, 2026 | No | – | No | – |
Other Events Investors Should Track
Beyond the regular earnings updates, there can be other things worth your attention:
- Upcoming investor conferences Guardant Health might attend
- FDA approvals or major product launches, since they can move the stock
- Updates about partnerships or business expansions
All in all, make sure to revisit their official IR site or media releases regularly. Things tend to move fast in the biotech space, and you don’t want to be caught off guard when big news drops.
Guardant Health Company Profile and Leadership
About Guardant Health’s Mission
Guardant Health is all about trying to help people live longer, cancer-free lives. They’re a precision oncology company, which sounds fancy, but basically, they use advanced tests – think blood and tissue – along with real-world data and AI to figure out what’s causing diseases like cancer. The goal is to make care better at every step, from catching cancer early to keeping an eye on it after treatment and helping doctors pick the right treatments.
Key Executive Team Members
It takes a team to run a company like this, and Guardant Health has a few key people at the helm:
- Helmy Eltoukhy Ph.D.: He’s the Chairperson of the Board and also serves as a Co-Chief Executive Officer.
- Michael Bell: He’s the Chief Financial Officer, handling the money side of things.
- Darya Chudova: She’s the Chief Technology Officer, likely overseeing all the tech development.
- Kumud Kalia: As the Chief Information Officer, she’s probably in charge of the company’s IT systems.
Corporate Headquarters Location
If you ever need to send them mail or just want to know where they’re based, Guardant Health’s main office is located at:
3100 Hanover Street
Palo Alto, CA 94304
United States
Conclusion
So, that’s the latest on Guardant Health’s stock price today. The numbers keep moving, and it’s honestly a lot to keep up with sometimes. The company has seen some big swings over the past year, and with all the talk about their cancer screening tech, people are definitely watching. If you’re thinking about buying or selling, it’s probably smart to keep an eye on the news and check the numbers regularly. Remember, stock prices can change fast, and what looks like a trend one day can flip the next. As always, do your own research and maybe talk to a financial advisor if you’re not sure. Investing can be a wild ride, but staying informed helps a lot.
Frequently Asked Questions
What is Guardant Health’s stock symbol and where is it traded?
Guardant Health is traded on the NASDAQ stock exchange under the symbol GH.
What was the highest and lowest price for GH stock in the past year?
In the last 52 weeks, GH stock reached a high of $120.74 and a low of $34.88.
Does Guardant Health pay a dividend to its shareholders?
No, Guardant Health does not currently pay a dividend.
Who are the main leaders at Guardant Health?
Some key leaders include Helmy Eltoukhy, who is the Chairperson and Co-CEO, Michael Bell, the Chief Financial Officer, Darya Chudova, the Chief Technology Officer, and Kumud Kalia, the Chief Information Officer.
Where is Guardant Health’s main office located?
Guardant Health’s headquarters is at 3100 Hanover Street, Palo Alto, California, 94304, United States.
What does Guardant Health do?
Guardant Health is a healthcare company that uses blood and tissue tests, along with AI, to help find and monitor cancer. Their goal is to help people stay healthy and catch cancer early.
